Summary of Study ST003183
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001982. The data can be accessed directly via it's Project DOI: 10.21228/M8J14Q This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003183 |
Study Title | Campylobacter infection of young children in Colombia and its impact on the gastrointestinal metabolome |
Study Summary | Campylobacter infections are a leading cause of bacterial-derived gastroenteritis worldwide with particularly profound impacts on pediatric patients in low-and-middle income countries. It remains unclear how Campylobacter impacts these hosts, though it is becoming increasingly evident that it is a multifactorial process that depends on the host immune response, the gastrointestinal microbiota, various bacterial factors, and host nutritional status. Since these factors likely vary between adult and pediatric patients in different regions of the world, it is important that studies define these attributes in well characterized clinical cohorts in diverse settings. In this study, we analyzed the metabolomic profiles of asymptomatic and symptomatic pediatric patients in Colombia that were either infected or uninfected with Campylobacter during a case-controlled study on acute diarrheal disease. Using computational models, we identified fecal metabolites that were associated with Campylobacter infection and found that glucose-6-phosphate and homovanillic acid were the strongest predictors of infection in these pediatric patients, which suggest that colonocyte metabolism are impacted during infection. |
Institute | University of Tennessee |
Last Name | Johnson |
First Name | Jeremiah |
Address | 1311 Cumberland Avenue, Knoxville, TN, 37996, USA |
jjohn358@utk.edu | |
Phone | 8659746229 |
Submit Date | 2024-04-18 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzML |
Analysis Type Detail | LC-MS |
Release Date | 2024-09-19 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001982 |
Project DOI: | doi: 10.21228/M8J14Q |
Project Title: | Campylobacter infection of young children in Colombia and its impact on the gastrointestinal metabolome |
Project Type: | MS quantitative analysis |
Project Summary: | Campylobacter infections are a leading cause of bacterial-derived gastroenteritis worldwide with particularly profound impacts on pediatric patients in low-and-middle income countries. It remains unclear how Campylobacter impacts these hosts, though it is becoming increasingly evident that it is a multifactorial process that depends on the host immune response, the gastrointestinal microbiota, various bacterial factors, and host nutritional status. Since these factors likely vary between adult and pediatric patients in different regions of the world, it is important that studies define these attributes in well characterized clinical cohorts in diverse settings. In this study, we analyzed the metabolomic profiles of asymptomatic and symptomatic pediatric patients in Colombia that were either infected or uninfected with Campylobacter during a case-controlled study on acute diarrheal disease. Using computational models, we identified fecal metabolites that were associated with Campylobacter infection and found that glucose-6-phosphate and homovanillic acid were the strongest predictors of infection in these pediatric patients, which suggest that colonocyte metabolism are impacted during infection. |
Institute: | University of Tennessee |
Department: | Microbiology |
Laboratory: | Johnson |
Last Name: | Johnson |
First Name: | Jeremiah |
Address: | 1311 Cumberland Avenue, Knoxville, TN, 37996, USA |
Email: | jjohn358@utk.edu |
Phone: | 8659746229 |
Subject:
Subject ID: | SU003302 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample source | PCR positive | Diarrhea |
---|---|---|---|---|
SA346728 | CCN6 | Feces | No | No |
SA346729 | CCN5 | Feces | No | No |
SA346730 | CCN3 | Feces | No | No |
SA346731 | CCN7 | Feces | No | No |
SA346732 | CCN4 | Feces | No | No |
SA346733 | CCN9 | Feces | No | No |
SA346734 | CCN19 | Feces | No | No |
SA346735 | CCN13 | Feces | No | No |
SA346736 | CCN10 | Feces | No | No |
SA346737 | CCN2 | Feces | No | No |
SA346738 | CCN8 | Feces | No | No |
SA346739 | CCN1 | Feces | No | No |
SA346740 | CCN17 | Feces | No | Yes |
SA346741 | CCN18 | Feces | No | Yes |
SA346742 | CCN16 | Feces | No | Yes |
SA346743 | CCN15 | Feces | No | Yes |
SA346744 | CCN12 | Feces | No | Yes |
SA346745 | CCN14 | Feces | No | Yes |
SA346746 | CCN11 | Feces | No | Yes |
SA346747 | CCN20 | Feces | No | Yes |
SA346748 | CCP17 | Feces | Yes | No |
SA346749 | CCP4 | Feces | Yes | No |
SA346750 | CCP16 | Feces | Yes | No |
SA346751 | CCP18 | Feces | Yes | No |
SA346752 | CCP19 | Feces | Yes | No |
SA346753 | CCP20 | Feces | Yes | No |
SA346754 | CCP2 | Feces | Yes | Yes |
SA346755 | CCP3 | Feces | Yes | Yes |
SA346756 | CCP7 | Feces | Yes | Yes |
SA346757 | CCP12 | Feces | Yes | Yes |
SA346758 | CCP13 | Feces | Yes | Yes |
SA346759 | CCP14 | Feces | Yes | Yes |
SA346760 | CCP1 | Feces | Yes | Yes |
SA346761 | CCP10 | Feces | Yes | Yes |
SA346762 | CCP9 | Feces | Yes | Yes |
SA346763 | CCP6 | Feces | Yes | Yes |
SA346764 | CCP15 | Feces | Yes | Yes |
SA346765 | CCP8 | Feces | Yes | Yes |
SA346766 | CCP5 | Feces | Yes | Yes |
Showing results 1 to 39 of 39 |
Collection:
Collection ID: | CO003295 |
Collection Summary: | Stool samples were collected from children aged two weeks to 59 months on either the day of enrollment or up to one-week post-enrollment from August to December 2014. Samples were collected in disposable plastic containers and transported to the Laboratoriode Investigaciones Biomédicas y Biotecnológicas (LIBB) at the Universidad de Santander, Bucaramanga, Colombia within four hours. Once samples were examined for color, consistency, presence of blood and/or mucus, aliquots were made and stored at -80°C. The samples were tested for viral, parasitic, and bacterial infections, including adenovirus, astrovirus, norovirus, rotavirus, sapovirus, Entamoeba histolytica, Giardia lamblia, Cryptosporidium spp., Campylobacter spp., Salmonella spp., Shigella spp., Yersinia spp., enteroaggregative Escherichia coli, diffuse-adhering E. coli, enteropathogenic E. coli, enteroinvasive E. coli, and enterotoxigenic E. coli. Campylobacter was detected by isolating on Campylosel agar (Biomerieux) and confirmed using API CAMPY (Biomerieux) and quantitative PCR (qPCR) as previously described. Briefly, human stool samples were diluted 1:10 in DEPC-treated water (Life Technologies), vortexed, and centrifuged. DNA was extracted using a QIAamp DNA stool mini kit (Qiagen) and stored at −20°C. A qPCR assay for C. jejuni and C. coli were conducted on a CFX96 Touch™ Real-Time PCR System as previously described (Bio-Rad). Each well included a 25 µl reaction mixture with 1 µl of DNA, 12.5 µl of TaqMan® environmental master mix, 9 µl of nuclease free water, 1 µl of each primer: cadF-Forward (5’-CTGCTAAACCATAGAAATAAAATTTCTCAC-3’) and cadF-Reverse (5’-CTTTGAAGGTAATTTAGATATGGATAATCG-3’) at a final concentration of 0.4 µM, and 0.5 µl of cadF-Probe (5’-[HEX]-CATTTTGACGATTTTTGGCTTGA-[BHQ2]-3’) at a final concentration of 0.2 µM. The cycling conditions were as follows: 95°C for 10 min, followed by 45 cycles of 95°C for 15 s and 55°C for 1 min. |
Sample Type: | Feces |
Treatment:
Treatment ID: | TR003311 |
Treatment Summary: | None |
Sample Preparation:
Sampleprep ID: | SP003309 |
Sampleprep Summary: | Metabolites were extracted from participant fecal samples by adding 0.650 mL of Metabolic Extraction Solvent (MES) (20:40:40 H2O:ACN:MeOH + 0.1 M Formic acid) to 0.1 gram of sample and mixing thoroughly before adding another 0.650 mL of MES and chilling at -20°C for 20 minutes. Samples were centrifuged (4°C at 13,500 rpm) and the supernatant was transferred to a fresh microcentrifuge tube and stored at 4°C. The resulting pellet was resuspended in 0.2 mL of MES and chilled at -20°C for 20 minutes before centrifugation and transfer of the supernatant to a fresh microcentrifuge tube. The samples were put on ice and transported to the Biological and Small Molecule Mass Spectrometry Core (BSMMSC) of the University of Tennessee where the supernatants were dried under nitrogen and the resulting pellets resuspended in 0.300 mL of milliQ H2O before being transferred to autosampler vials. |
Combined analysis:
Analysis ID | AN005227 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Dionex UltiMate 3000 UHPLC |
Column | Phenomonex Synergi Hydro RP (100 x 2.0 mm, 2.5 um) |
MS Type | ESI |
MS instrument type | Orbitrap |
MS instrument name | Thermo Q Exactive Plus Orbitrap |
Ion Mode | NEGATIVE |
Units | relative abundance |
Chromatography:
Chromatography ID: | CH003954 |
Instrument Name: | Dionex UltiMate 3000 UHPLC |
Column Name: | Phenomonex Synergi Hydro RP (100 x 2.0 mm, 2.5 um) |
Column Temperature: | 25 |
Flow Gradient: | mobile phase A during the 25-minute method was 100% at minute zero, 80% at minute 5, 45% at minute 13, 5% at minute 15.5, and 100% at minute 19 and 25, while the mobile phase B gradient equalized the percentage |
Flow Rate: | 0.2 mL/minute |
Solvent A: | 97% methanol/3% water; 11 mM tributylamine; 15 mM acetic acid |
Solvent B: | 100% methanol |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS004960 |
Analysis ID: | AN005227 |
Instrument Name: | Thermo Q Exactive Plus Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | scan range of 72-1000 m/z |
Ion Mode: | NEGATIVE |